Better warfarin therapy for atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a better way to manage warfarin (a blood thinner) for people with atrial fibrillation (an irregular heartbeat). The goal is to improve treatment and help prevent stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You must be taking warfarin or have been told you need to start taking it
- You must have atrial fibrillation (a type of irregular heartbeat)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
This study looks for unique metabolic patterns in people with atrial fibrillation (an irregular heartbeat). The goal is to develop personalized prevention strategies by comparing these patterns between patients and healthy volunteers.
This study is testing if an AI program can help doctors choose better treatments for atrial fibrillation (AF). It is for people who were recently diagnosed with AF and have noticeable symptoms.
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
This trial tests whether a target heart rate (below 80 beats per minute) is better than a more lenient one for people with persistent or permanent atrial fibrillation. It aims to find the best way to control your heart rate and improve your quality of life.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.